Current data regarding the structure-toxicity relationship of boron-containing compounds.

Area of Science:

• Medicinal Chemistry
• Toxicology
• Drug Discovery

Background:

• Boron is an essential element with a long history of human exposure through various compounds.
• Boron-containing compounds (BCCs) have been utilized in antiseptics, antibiotics, and insecticides, with early uses like boric acid revealing significant toxicity.
• Extensive toxicological studies have since informed the safe application limits of BCCs.

Purpose of the Study:

• To review toxicological data of BCCs from experimental models.
• To summarize the structure-activity relationships concerning the toxicity and therapeutic applications of BCCs.
• To explore the potential of new technologies in developing effective and safe BCC-based therapeutics.

Main Methods:

• Review of experimental toxicological data for BCCs.
• Analysis of structure-activity relationships for BCCs in therapeutic contexts.
• Discussion of emerging technologies for BCC drug discovery.

Main Results:

• Historical use of BCCs, such as boric acid, demonstrated critical human toxicity.
• Recent research shows that incorporating boron into known drugs can enhance their affinity and selectivity.
• The biological activity and toxicity of BCCs are intrinsically linked to their chemical structure.

Conclusions:

• Understanding the structure-activity relationship is crucial for both therapeutic efficacy and mitigating toxicity of BCCs.
• New technological approaches are vital for discovering potent and selective BCCs for medicinal applications.
• Future research should focus on designing BCCs that maximize therapeutic benefits while minimizing adverse effects.